Literature DB >> 28011314

Idarucizumab (Praxbind): The First Reversal Agent for a Direct Oral Anticoagulant.

Shannon W Finks1, Kelly C Rogers1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28011314     DOI： 10.1016/j.amjmed.2016.11.029

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  2 in total

Review 1.  Perioperative Management of New Oral Anticoagulants in Urological Surgery.

Authors:  Eva Browne; Usman Haroon; Niall F Davis; James C Forde
Journal:  Curr Urol       Date:  2018-03-30

Review 2.  Periprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures.

Authors:  Shannon W Finks; Paul P Dobesh; Toby C Trujillo; George H Crossley
Journal:  Cardiol Rev       Date:  2018 Sep/Oct       Impact factor: 2.644
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.